REQUEST A DEMO
Total
USD $0.00
Search more companies

Epidbiomed-Impeks OOO (Эпидбиомед-Импэкс ООО) (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Epidbiomed-Impeks OOO Profile Updated: October 16, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Epidbiomed-Impeks OOO (Эпидбиомед-Импэкс ООО) is a company based in Russia, with its head office in Moscow. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on January 29, 2004. Epidbiomed-Impeks OOO (Эпидбиомед-Импэкс ООО) currently employs 76 (2023) people. In its most recent financial highlights, the company reported a net sales revenue increase of 34.28% in 2025. A negative growth of 3.99% was recorded in its total assets. In 2025, Epidbiomed-Impeks OOO (Эпидбиомед-Импэкс ООО)’s net profit margin increased by 1.5%.

Headquarters
7-Ya Kozhuhovskaya, 20
Moscow; Moscow; Postal Code: 115193

Contact Details: Purchase the Epidbiomed-Impeks OOO (Эпидбиомед-Импэкс ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Epidbiomed-Impeks OOO (Эпидбиомед-Импэкс ООО) report to view the information.
Registered Capital:
Purchase the Epidbiomed-Impeks OOO (Эпидбиомед-Импэкс ООО) report to view the information.
Financial Auditors:
Purchase the Epidbiomed-Impeks OOO (Эпидбиомед-Импэкс ООО) report to view the information.
Incorporation Date:
January 29, 2004
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Subsidiaries
Npo Epidbiomed AO
50%
Company Performance
Financial values in the chart are available after Epidbiomed-Impeks OOO (Эпидбиомед-Импэкс ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
34.28%▲
Total Operating Revenue
34.28%▲
Operating Profit
N/A
Net Profit/Loss for the Period
97.23%▲
Total Assets
-3.99%▼
Total Equity
27.19%▲
Operating Profit Margin
N/A
Net Profit Margin
1.5%▲
Return on Equity (ROE)
17.58%▲
Quick Ratio
0.46%▲
Cash Ratio
0.35%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?